· Published by Health Canada · Official notice
This is duplicated text of a letter from Baxter Corporation. Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
September 20, 2014
Dear Renal Program Manager, Director of Nephrology and Director of Dialysis Unit,
Please distribute to relevant Departments (Nephrology, Pharmacy, Paediatrics, Internal Medicine, Nursing, Intensive Care and/or other Departments as required, Dialysis Unit and Dialysis Clinics associated with your hospital), other involved professional staff and post this notice in all relevant areas of your institution.
Subject: Recall of one (1) lot of Baxter Calcium-45, 24 EA/CA (DIN: 02160986) due to Missing Bottle Labels (Product Code: CA50, Lot Number: W4A07S0)
Baxter Corporation in consultation with Health Canada has initiated an Urgent Product Recall for one (1) lot of Calcium-45, 24 EA/CA, due to missing bottle labels. The affected lot (Lot Number: W4A07S0) has been distributed in Canada between February 07, 2014 and April 24, 2014.
Calcium-45 is used as an additive for creating the prescribed calcium concentration for dialysate used for hemodialysis treatments.
Baxter is recalling the following Calcium additive lot.
Description: Calcium-45, Product Code: CA50, Lot Number: W4A07S0
The specified lot should not be used. Contact Baxter Customer Care at 1-888-719-9955 to arrange for return and credit of the affected lot number. Baxter is currently investigating this issue and has not received any reports of adverse events for the specified lot.
Managing marketed health product-related adverse reactions depends on health care professionals and consumers reporting them. Reporting rates determined on the basis of spontaneously reported post-market adverse reactions are generally presumed to underestimate the risks associated with health product treatments. Any cases of serious or unexpected adverse reactions in patients receiving Calcium-45 should be reported to Baxter or Health Canada.
Baxter Corporation
Mailing address:
Attn: Pharmacovigilance
7125 Mississauga Road
Mississauga, ON
L5N 0C2
Phone: 1-800-387-8399 ext 6607
E-Mail: canada_pharmacovigilance@baxter.com
Fax: 1-855-767-4573
To correct your mailing address or fax number, contact Baxter Customer Care at 1-888-719-9955.
You can report any suspected adverse reactions associated with the use of health products to Health Canada by:
For other health product inquiries related to this communication, contact Health Canada at:
Health Products and Food Branch Inspectorate
E-mail: DCVIU_UVCEM@hc-sc.gc.ca
Telephone: 1-800-267-9675
Fax: 613-946-5636
For questions related to the return of affected Calcium-45, (Product Code: CA50, Lot Number: W4A07S0), please contact Baxter Customer Care at 1-888-719-9955.
Sincerely,
original signed by
Danielle Tokarski
Quality Systems Manager
Baxter Corporation